News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Full results and Plain Language Summary for CheckMate 77T trial – NEJM
Photo of NEJM from tukuz.com
May 28, 2024, 07:48

Full results and Plain Language Summary for CheckMate 77T trial – NEJM

NEJM shared on X/Twitter:

“In the CheckMate 77T trial, researchers assessed whether adding adjuvant nivolumab to neoadjuvant nivolumab plus chemotherapy would improve outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Full results and Plain Language Summary.”

Perioperative Nivolumab in Resectable Lung Cancer A PLAIN LANGUAGE SUMMARY Top Figure: Illustration of treatment options during the Neoadjuvant and Adjuvant Periods. Bottom Figure: Graph of the Percentage of Patients with Event-free Survival

Source: NEJM/X

adjuvant nivolumab cancer CheckMate 77T trial NEJM neoadjuvant nivolumab OncoDaily Oncology resectable NSCLC
Special Coverage
Blog
Dec 18, 2024, 18:42
Antonio Giordano: Dana-Farber’s CCTI team expanding interests and growing with Glenn J. Hanna leadership
Blog
Dec 18, 2024, 18:36
Stacey Tinianov on quality of life with patients while discussing new therapies
Blog
Dec 18, 2024, 18:34
Razelle Kurzrock: Pleasure to give talk for Cancer Precision Medicine Commons
Blog
Dec 18, 2024, 18:31
Yao Zhu: Honored to join Journal of Clinical Oncology as an editor
Science
Dec 18, 2024, 18:28
Yannick R.: The changing global landscape of national cancer control plans
Blog
Dec 18, 2024, 18:24
Triparna Sen: Grateful to have been invited as a speaker at the LALCA24
Blog
Dec 18, 2024, 18:20
Angie Rolle: ACS is seeking a results-driven leader to join as Vice President - Community Impact
Insight
Dec 18, 2024, 18:18
"2024's top 10 advances in medicine" suggested by Samuel Hume
Blog
Dec 18, 2024, 18:12
Divij Verma: The increased risk of pre-leukemic clonal hematopoiesis in 9/11-exposed first responders
Blog
Dec 18, 2024, 18:09
Narjust Florez: Our EQUAL study is about to launch
Blog
Dec 18, 2024, 18:05
The Adoption of the IASLC 9th Edition TNM Classification System for Lung Cancer
Blog
Dec 18, 2024, 18:02
ASCO25 is the place to be innovative